Does PACLITAXEL Cause Hyperbilirubinaemia? 127 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 127 reports of Hyperbilirubinaemia have been filed in association with PACLITAXEL (PACLITAXEL PACLITAXEL). This represents 0.2% of all adverse event reports for PACLITAXEL.
127
Reports of Hyperbilirubinaemia with PACLITAXEL
0.2%
of all PACLITAXEL reports
12
Deaths
52
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From PACLITAXEL?
Of the 127 reports, 12 (9.4%) resulted in death, 52 (40.9%) required hospitalization, and 7 (5.5%) were considered life-threatening.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PACLITAXEL. However, 127 reports have been filed with the FAERS database.
What Other Side Effects Does PACLITAXEL Cause?
Neutropenia (4,553)
Nausea (4,521)
Dyspnoea (4,519)
Diarrhoea (4,289)
Off label use (4,075)
Anaemia (3,949)
Neuropathy peripheral (3,508)
Malignant neoplasm progression (3,484)
Fatigue (3,418)
Death (3,143)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)
Which PACLITAXEL Alternatives Have Lower Hyperbilirubinaemia Risk?
PACLITAXEL vs PACRITINIB
PACLITAXEL vs PALBOCICLIB
PACLITAXEL vs PALIPERIDONE
PACLITAXEL vs PALIVIZUMAB
PACLITAXEL vs PALONOSETRON